| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Veterinary Medical Diagnostic Laboratory, College of Veterinary Medicine, University of Missouri, PO Box 6023, Columbia, MO
Diagnostic records from 338 canine oral melanomas in 338 dogs received at the Veterinary Medical Diagnostic Laboratory (1992–1999) were reviewed. Of these tumors, 122 plus an additional 7 metastatic melanomas of unknown origin were selected for clinical follow-up, histologic review, and immunohistochemistry. Chow Chow, Golden Retriever, and Pekingese/Poodle mix breeds were overrepresented, whereas Boxer and German Shepherd breeds were underrepresented. There was no gender predisposition and the average age at presentation was 11.4 years. Forty-nine dogs were euthanized due to recurrence or metastasis. The average postsurgical survival time was 173 days. The gingiva and the labial mucosa were the most common sites. Most tumors were composed of either polygonal cells (27 cases, 20.9%), spindle cells (44 cases, 34.1%), or a mixture of the two (polygonal and spindle) (54 cases, 41.9%). Clear cell (3 cases, 2.3%) and adenoid/papillary (1 case, 0.8%) patterns were uncommon. The metastases of 6/6 oral melanomas had morphologic and immunohistochemical features similar to those of the primary tumors. Immunohistochemically, Melan A was detected in 113/122 oral (92.6%) and 5/7 (71.9%) metastatic melanomas. Only 4/163 nonmelanocytic tumors were focally and weakly positive for Melan A. Antibodies against vimentin, S100 protein, and neuron-specific enolase stained 129 (100%), 98 (76%), and 115 (89.1%) of 129 melanomas, respectively. Antibodies against other melanocytic-associated antigens (tyrosinase, glycoprotein 100) did not yield adequate staining. We conclude that Melan A is a specific and sensitive marker for canine melanomas.
Key words: Canine; Epidemiology; Histopathology; Immunohistochemistry; Melan A; Melanoma; Metastasis; Oral.
Request reprints from Dr. José A. Ramos-Vara, Veterinary Medical Diagnostic Laboratory, University of Missouri, PO Box 6023, Columbia, MO 65205 (USA).
This article has been cited by other articles:
 |
|
 |
|
  D. G. Esplin Survival of Dogs Following Surgical Excision of Histologically Well-differentiated Melanocytic Neoplasms of the Mucous Membranes of the Lips and Oral Cavity Vet. Pathol., November 1, 2008; 45(6): 889 - 896. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Ramos-Vara, M. Kiupel, T. Baszler, L. Bliven, B. Brodersen, B. Chelack, S. Czub, F. D. Piero, S. Dial, E.J. Ehrhart, et al. Suggested guidelines for immunohistochemical techniques in veterinary diagnostic laboratories J Vet Diagn Invest, July 1, 2008; 20(4): 393 - 413. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Stefanello, S. Romussi, P. Signorelli, M. Caniatti, M. DiGiancamillo, P. Roccabianca, and G. Avallone Primary Osseous Melanoma in the Tibia of a Dog J. Am. Anim. Hosp. Assoc., May 1, 2008; 44(3): 139 - 143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Owston and J. A. Ramos-Vara Histologic and Immunohistochemical Characterization of a Testicular Mixed Germ Cell Sex Cord-Stromal Tumor and a Leydig Cell Tumor in a Dog Vet. Pathol., November 1, 2007; 44(6): 936 - 943. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Sanchez, G. A. Ramirez, A. J. Buendia, M. Vilafranca, C. M. Martinez, J. Altimira, and J. A. Navarro Immunohistochemical Characterization and Evaluation of Prognostic Factors in Canine Oral Melanomas with Osteocartilaginous Differentiation Vet. Pathol., September 1, 2007; 44(5): 676 - 682. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Shimoyama, Y. Akihara, D. Kirat, H. Iwano, K. Hirayama, Y. Kagawa, T. Ohmachi, K. Matsuda, M. Okamoto, T. Kadosawa, et al. Expression of Monocarboxylate Transporter 1 in Oral and Ocular Canine Melanocytic Tumors Vet. Pathol., July 1, 2007; 44(4): 449 - 457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. L. Spangler and P. H. Kass The histologic and epidemiologic bases for prognostic considerations in canine melanocytic neoplasia. Vet. Pathol., February 1, 2006; 43(2): 136 - 149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Ramos-Vara Technical Aspects of Immunohistochemistry Vet. Pathol., July 1, 2005; 42(4): 405 - 426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Ramos-Vara, M. A. Miller, and G. C. Johnson Usefulness of Thyroid Transcription Factor-1 Immunohistochemical Staining in the Differential Diagnosis of Primary Pulmonary Tumors of Dogs Vet. Pathol., May 1, 2005; 42(3): 315 - 320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Choi and D. F. Kusewitt Comparison of Tyrosinase-related Protein-2, S-100, and Melan A Immunoreactivity in Canine Amelanotic Melanomas Vet. Pathol., November 1, 2003; 40(6): 713 - 718. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Mikaelian and V. Wong Follicular Stem Cell Carcinoma: Histologic, Immunohistochemical, Ultrastructural, and Clinical Characterization in 30 Dogs Vet. Pathol., July 1, 2003; 40(4): 433 - 444. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Bergman, J. McKnight, A. Novosad, S. Charney, J. Farrelly, D. Craft, M. Wulderk, Y. Jeffers, M. Sadelain, A. E. Hohenhaus, et al. Long-Term Survival of Dogs with Advanced Malignant Melanoma after DNA Vaccination with Xenogeneic Human Tyrosinase: A Phase I Trial Clin. Cancer Res., April 1, 2003; 9(4): 1284 - 1290. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Smith, M. H. Goldschmidt, and P. M. McManus A Comparative Review of Melanocytic Neoplasms Vet. Pathol., November 1, 2002; 39(6): 651 - 678. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Ramos-Vara, M. A. Miller, G. C. Johnson, S. E. Turnquist, J. M. Kreeger, and G. L. Watson Melan A and S100 Protein Immunohistochemistry in Feline Melanomas: 48 Cases Vet. Pathol., January 1, 2002; 39(1): 127 - 132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Tunev and M. G. Wells Cutaneous Melanoma in a Ferret (Mustela putorius furo) Vet. Pathol., January 1, 2002; 39(1): 141 - 143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Ramos-Vara, M. A. Miller, and G. C. Johnson Immunohistochemical Characterization of Canine Hyperplastic Hepatic Lesions and Hepatocellular and Biliary Neoplasms with Monoclonal Antibody Hepatocyte Paraffin 1 and a Monoclonal Antibody to Cytokeratin 7 Vet. Pathol., November 1, 2001; 38(6): 636 - 643. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Koenig, J. Wojcieszyn, B. R. Weeks, and J. F. Modiano Expression of S100a, Vimentin, NSE, and Melan A/MART-1 in Seven Canine Melanoma Cell Lines and Twenty-nine Retrospective Cases of Canine Melanoma Vet. Pathol., July 1, 2001; 38(4): 427 - 435. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
